According to a new report, the market for artificial intelligence (AI) platforms for the entire healthcare industry will grow from $1.5 billion in 2019 to $4.3 billion in 2024. This is due to the additional integration of digital health tools and technologies such as AI and machine learning (ML) in the healthcare industry due to the impact of the COVID-19 pandemic, said a report by data and analytics company GlobalData.
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems. French biotechnology company Genomic Vision, which specializes in the development and commercialization of diagnostic solutions for genetic diseases and cancer, recently launched FiberSmart, a new technology that enables the visualization and analysis of long DNA fibers at high resolution. Makes
Genomic Vision claims that FiberSmart has the potential to improve the accuracy and efficiency of genetic disease diagnosis and treatment, leading to better patient outcomes and reduced healthcare costs.
Kamila Kahn, Medical Analyst at GlobalData, said, “The integration of digital health tools and technologies such as AI and ML to analyze massive amounts of data and identify patterns and insights is transforming the healthcare industry and enabling more personalized and efficient healthcare. paving the way for service. said in a statement.
In addition, AI is being used to improve the accuracy and efficiency of diagnosis, identify new treatments and therapies, and even predict and prevent disease outbreaks.
“The growing market for AI platforms in healthcare reflects a growing demand for innovative solutions that can improve patient outcomes and reduce costs,” Kan said.
The post AI Platform Market for Healthcare Industry to Reach $4.3 Billion in 2024: The Report appeared first on Techlusive.